RTI-7470-44

Catalog No. :
ACNVQH567
CAS No. :
825658-63-7
Molecular Formula :
C19H11ClF3N5OS
Molecular Weight :
449.85

IUPAC Name:2-((6-(4-chlorophenyl)-3-cyano-4-(trifluoromethyl)pyridin-2-yl)thio)-N-(pyrimidin-2-yl)acetamide

RTI-7470-44 structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$84.00Login to see priceInquiryInquiry
5mg98%$188.00Login to see priceInquiryInquiry
10mg98%$283.00Login to see priceIn stockInquiry
25mg98%$537.00Login to see priceIn stockInquiry
50mg98%$913.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameRTI-7470-44
IUPAC Name2-((6-(4-chlorophenyl)-3-cyano-4-(trifluoromethyl)pyridin-2-yl)thio)-N-(pyrimidin-2-yl)acetamide
Molecular FormulaC19H11ClF3N5OS
Molecular Weight449.85
SMILESO=C(NC1=NC=CC=N1)CSC2=NC(C3=CC=C(Cl)C=C3)=CC(C(F)(F)F)=C2C#N
InChI KeyWHNQNKYKDSLDKM-UHFFFAOYSA-N
SynonymAcetamide, 2-[[6-(4-chlorophenyl)-3-cyano-4-(trifluoromethyl)-2-pyridinyl]thio]-N-2-pyrimidinyl-;RTI-7470-44
CAS No.825658-63-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACNVQH567 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIDRO763 route compound structure diagram
    ACIDRO763109-12-6 In Stock
  4. Then
  5. ACNVQH567 route product structure diagram
    ACNVQH567825658-63-7 In Stock
Inquiry

2. ACNVQH567 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNVQH567 route product structure diagram
    ACNVQH567825658-63-7 In Stock
Inquiry

Comments (0)